IL135799A0 - Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration - Google Patents
Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regenerationInfo
- Publication number
- IL135799A0 IL135799A0 IL13579998A IL13579998A IL135799A0 IL 135799 A0 IL135799 A0 IL 135799A0 IL 13579998 A IL13579998 A IL 13579998A IL 13579998 A IL13579998 A IL 13579998A IL 135799 A0 IL135799 A0 IL 135799A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- nervous system
- central nervous
- neuronal regeneration
- mammalian central
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000006386 Myelin Proteins Human genes 0.000 title abstract 3
- 108010083674 Myelin Proteins Proteins 0.000 title abstract 3
- 210000005012 myelin Anatomy 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 230000009689 neuronal regeneration Effects 0.000 title 1
- 102000000989 Complement System Proteins Human genes 0.000 abstract 2
- 108010069112 Complement System Proteins Proteins 0.000 abstract 2
- 208000016192 Demyelinating disease Diseases 0.000 abstract 1
- 206010012305 Demyelination Diseases 0.000 abstract 1
- 230000009693 chronic damage Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000001052 transient effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2219683 CA2219683A1 (en) | 1997-10-28 | 1997-10-28 | Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration |
| CA2251410 | 1998-10-16 | ||
| PCT/CA1998/000997 WO1999021581A1 (en) | 1997-10-28 | 1998-10-28 | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL135799A0 true IL135799A0 (en) | 2001-05-20 |
Family
ID=25679779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13579998A IL135799A0 (en) | 1997-10-28 | 1998-10-28 | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
| IL135799A IL135799A (en) | 1997-10-28 | 2000-04-24 | Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL135799A IL135799A (en) | 1997-10-28 | 2000-04-24 | Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6548061B1 (de) |
| EP (1) | EP1047449B1 (de) |
| JP (1) | JP2001521008A (de) |
| AT (1) | ATE249241T1 (de) |
| AU (1) | AU748143B2 (de) |
| DE (1) | DE69818106T2 (de) |
| DK (1) | DK1047449T3 (de) |
| ES (1) | ES2210829T3 (de) |
| IL (2) | IL135799A0 (de) |
| PT (1) | PT1047449E (de) |
| WO (1) | WO1999021581A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002542299A (ja) * | 1999-04-28 | 2002-12-10 | ユニバーシティ・オブ・ブリティッシュ・コロンビア | ミエリン特異性抗体および補体タンパク質を含むニューロン再生用組成物 |
| GB0103174D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Plc | Novel method of treatment |
| TWI323265B (en) * | 2002-08-06 | 2010-04-11 | Glaxo Group Ltd | Antibodies |
| GB0306309D0 (en) | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
| LT3028716T (lt) | 2006-10-10 | 2020-12-10 | Regenesance B.V. | Komplemento slopinimas nervų regeneracijos pagerinimui |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| UY35468A (es) | 2013-03-16 | 2014-10-31 | Novartis Ag | Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19 |
| US10058471B2 (en) * | 2014-02-21 | 2018-08-28 | William M. Vaughan | System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries |
| AU2015244039B2 (en) | 2014-04-07 | 2021-10-21 | Novartis Ag | Treatment of cancer using anti-CD19 chimeric antigen receptor |
| MX2017012939A (es) | 2015-04-08 | 2018-05-22 | Novartis Ag | Terapias cd20, terapias cd22 y terapias de combinacion con una celula que expresa un receptor quimerico de antigeno (car) de cd19. |
| EP3523331A1 (de) | 2016-10-07 | 2019-08-14 | Novartis AG | Chimäre antigenrezeptoren zur behandlung von krebs |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002003A1 (en) * | 1989-08-04 | 1991-02-21 | Board Of Regents, The University Of Texas System | Methods and compositions; purified preparation of neural progenitor regulatory factor |
| US6020140A (en) * | 1991-08-09 | 2000-02-01 | Washington University | Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| ES2140463T3 (es) * | 1992-06-12 | 2000-03-01 | Cephalon Inc | Prevencion y tratamiento de la neuropatia periferica. |
| US5714385A (en) * | 1995-05-10 | 1998-02-03 | Genentech, Inc. | Media for culturing schwann cells |
| US6228598B1 (en) * | 1998-10-02 | 2001-05-08 | Washington University | Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies |
-
1998
- 1998-10-28 JP JP2000517739A patent/JP2001521008A/ja active Pending
- 1998-10-28 ES ES98949847T patent/ES2210829T3/es not_active Expired - Lifetime
- 1998-10-28 EP EP98949847A patent/EP1047449B1/de not_active Expired - Lifetime
- 1998-10-28 US US09/181,719 patent/US6548061B1/en not_active Expired - Fee Related
- 1998-10-28 AU AU96179/98A patent/AU748143B2/en not_active Ceased
- 1998-10-28 AT AT98949847T patent/ATE249241T1/de not_active IP Right Cessation
- 1998-10-28 DE DE69818106T patent/DE69818106T2/de not_active Expired - Lifetime
- 1998-10-28 DK DK98949847T patent/DK1047449T3/da active
- 1998-10-28 US US09/530,234 patent/US6969516B1/en not_active Expired - Fee Related
- 1998-10-28 WO PCT/CA1998/000997 patent/WO1999021581A1/en not_active Ceased
- 1998-10-28 IL IL13579998A patent/IL135799A0/xx active IP Right Grant
- 1998-10-28 PT PT98949847T patent/PT1047449E/pt unknown
-
2000
- 2000-04-24 IL IL135799A patent/IL135799A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU9617998A (en) | 1999-05-17 |
| AU748143B2 (en) | 2002-05-30 |
| ES2210829T3 (es) | 2004-07-01 |
| WO1999021581A1 (en) | 1999-05-06 |
| DK1047449T3 (da) | 2004-01-26 |
| EP1047449A1 (de) | 2000-11-02 |
| EP1047449B1 (de) | 2003-09-10 |
| IL135799A (en) | 2011-01-31 |
| US6548061B1 (en) | 2003-04-15 |
| JP2001521008A (ja) | 2001-11-06 |
| DE69818106T2 (de) | 2004-06-17 |
| ATE249241T1 (de) | 2003-09-15 |
| US6969516B1 (en) | 2005-11-29 |
| PT1047449E (pt) | 2004-04-30 |
| DE69818106D1 (de) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135799A0 (en) | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration | |
| Narayanan et al. | Biosynthesis and regulation of type V collagen in diploid human fibroblasts. | |
| KR910001057A (ko) | 이중특이성 및 올리고특이성 일가 및 올리고가 수용체. 이의 제조방법 및 이의 용도 | |
| DK1194167T3 (da) | Immunoterapi af autoimmune sygdomme under anvendelse af B-cellespecifikke antistoffer | |
| NL300372I1 (nl) | Hybride immunoglobulinen voor gebruik bij therapeutische werkwijzen | |
| ATE151113T1 (de) | Fusionsproteine von monomeren und dimeren von antikörperfragmenten | |
| DE69119278D1 (de) | Monoklonaler Antikörper, der mit einer neuen HLA-Determinante auf MHC-Klasse-I-Moleküle reagiert, und Verfahren zur Aktivierung von Lymphozyten | |
| MX7235E (es) | Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| ATE248605T1 (de) | Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper | |
| EP0097518A3 (en) | Monoclonal antibody | |
| DK121788D0 (da) | Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse | |
| ATE403001T1 (de) | Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs | |
| ATE112687T1 (de) | Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen. | |
| BR9810409A (pt) | Métodos e composições para a modulação de responsividade a corticosteróides | |
| AU3066489A (en) | Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore | |
| DE68925593D1 (de) | Antikörper-Heterokonjugate zur Regulation der Lymphozytenaktivität | |
| DE69531290D1 (de) | Antigen-besierende heteropolymere zur behandlung von autoimmunkrankheiten mittels diesen | |
| PT99770A (pt) | Processo para a preparacao de receptores de glutamato acoplados com proteina g de mamiferos | |
| AU4626389A (en) | Use of minoxidil for wound healing | |
| EA199900409A1 (ru) | Растворимые рецепторы бета-лимфотоксина, антитела против рецепторов лимфотоксина и антитела против лимфотоксиновых лигандов как терапевтические агенты для лечения иммунологических заболеваний | |
| CA2253078A1 (en) | Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration | |
| EA199900522A1 (ru) | Полипептиды, кодируемые геном, подобным гену липазы человека, композиции и методы | |
| DE69432472D1 (de) | Verfahren zur hemmung der phagozytose | |
| NO892125D0 (no) | Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted |